February 2014

The annual conference of the CTrials, the Israeli Association for the advancement of the biomedical research community and clinical trials in Israel, will be held on April 3rdin The Chaim Sheba Medical Center (Hebrew).
The Israeli annual conference for Clinical Trials will be held on April 29th in David Intercontinental hotel in Tel Aviv. Clinical research undergoes significant changes in domestic and engaged in this field need to be revised to meet the new regulatory standards. At this conference we will refer to a variety of relevant disciplines in the field, including practical workshop management tools based GCP clinical trial, relating to the requirements of the latest health authorities in Israel and abroad. The conference is intended for all engaged in clinical trials in Israel.
The Administration of medical technologies and infrastructure of the Israeli Ministry of Health is holding a seminar about preparation of the health system for the change on the clinical trials guidelines. The seminar will be held on March 5th in Sheba medical center.
Link to the seminar invitation
CTrials, The Israeli Association for the advancement of the biomedical research community and clinical trials in Israel, published their comments regarding the proposed changes of the clinical trials procedure by the Israeli Ministry of Health.
Ctrials comments (PDF)
Ctrials position paper (PDF)
2013 boom year for Israeli high-tech. In the first half of the year, there was a 52% rise in demand for mobile and web developers, and salaries are up as well. 2013 was a positive year for Israeli high-tech and biotech, in almost every respect: total investments rose, salaries rose, and there were some impressive exits. According to human resources and research company Ethosia, the mobile sector is still guiding the industry, and despite some worrisome signs, there is still room for much optimism.
GIVEN IMAGING GETS FDA CLEARANCE FOR COLON CAMERA PILL. Camera-in-a-pill maker Given Imaging said it received U.S. Food and Drug Administration clearance for a pill to provide visualization of the colon that has a global market of 3 million procedures a year. The pill, called the PillCam Colon, may be used for detection of colon polyps in patients after an incomplete optical colonoscopy, the Israeli medical device maker said.
GLAXOSMITHKLEIN AND TECHNION'S BIORAP JOIN HANDS ON IMMUNE SYSTEM DISEASE TREATMENT.  GlaxoSmithKline and BioRap will commercialize a treatment for lethal side effects of bone marrow transplants. Pharmaceutical giant GlaxoSmithKline plc (LSE: GSK) has signed a joint drug development agreement with BioRap Technologies Ltd., the technology transfer company of the Rappaport Family Institute for Research in the Biomedical Sciences at the Technion, Israel Institute of Technology in Haifa. GSK and BioRap will commercialize the Israeli company's molecule for the treatment of immune-system related diseases.
China Everbright to Invest $100 M in Israeli Companies. China Everbright and Israel-based Catalyst Equity Management have reached a first close of $100 million on a private equity fund that will invest in Israeli companies. The Catalyst CEL Fund, a joint vehicle announced last October, is looking to raise $200 million, with a hard cap of $300 million. China Everbright has provided $75 million as seed capital.
CHINA'S HAIER ESTABLISHES INNOVATION CENTER IN ISRAEL. Chinese electrical products manufacturer Haier announced plans to establish an innovation center in Israel, part of its strategy to integrate advanced technologies being developed in countries throughout the world into their own products.